Back to search
FDAFDA · Food and drugs·Recall number D-0590-2025

Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045, USA. NDC 0409-4933-05. Case: NDC 0409-4933-10.

Published August 27, 2025 · Recall initiated: August 4, 2025

Summary

FDA records drug Class II recall D-0590-2025, published August 27, 2025 and initiated August 4, 2025. Recalling firm: PFIZER INC; Status: Ongoing; Reported quantity: 49,620 vials; Lot: Lot #: LY3681, LY4360, LY4416, Exp. 02/28/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
PFIZER INC
Distributor
U.S. Nationwide
Lot
Lot #: LY3681, LY4360, LY4416, Exp. 02/28/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Vial Label: Epinephrine Injection, USP, 1mg/10mL (0.1 mg/mL), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045, USA. NDC 0409-4933-05. Case: NDC 0409-4933-10. recalled?

Yes. FDA published recall D-0590-2025 on August 27, 2025. Reported hazard: Lack of Assurance of Sterility.

What should I do if I have this product?

Voluntary: Firm initiated · Letter